• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.79% Nasdaq Up 0.16%

    Ariad Pharmaceuticals Inc. (ARIA)

    -NasdaqGS
    6.10 0.10(1.61%) Jan 23, 4:00PM EST
    |After Hours : 6.07 Down 0.03 (0.49%) Jan 23, 7:38PM EST
    Add to Portfolio
    Prev Close:6.20
    Open:6.18
    Bid:N/A
    Ask:6.99 x 500
    1y Target Est:7.96
    Beta:0.9
    Next Earnings Date:18-Feb-15ARIA Earnings announcement
    Day's Range:6.02 - 6.23
    52wk Range:4.90 - 9.74
    Volume:3,073,623
    Avg Vol (3m):6,009,920
    Market Cap:1.14B
    P/E (ttm):N/A
    EPS (ttm):-1.24
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ARIA

    Comparison

    Symbol% ChgMkt Cap
    ARIADown 1.61%1.14B
    NVS234.30B
    PFE204.46B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):24.73
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.07
    Quarterly EPS Est (Dec-14) :-0.23
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):-0.14

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ARIAD Pharmaceuticals, Inc., an oncology company, is engaged in the discovery, development, and commercialization of medicines for cancer patients. It offers Iclusig (ponatinib), a tyrosine kinase inhibitor for the treatment of adult patients with... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback